Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562.
1239588-11-4
13195-64-7
13937-08-1
149577-05-9
20605-01-0
42726-73-8
66735-01-1 | 2-(4-Bromobenzyl)propanoic acid | AA00FGBK | MFCD12152839
66487-31-8 | 2-(1,2,3,4-tetrahydroquinolin-1-yl)acetonitrile | AA00FGOC | MFCD00100116
6965-63-5 | 2-Hydrazinyl-3-methyl-5-nitropyridine | AA00FGVY | MFCD10000005
7076-23-5 | (R)-3-(Pyrrolidin-2-yl)pyridine | AA00FH6N | MFCD09257346
720678-21-7 | 1-Chloro-3-fluoro-2-isocyanatobenzene | AA00FHLJ | MFCD08444547
72408-58-3 | 2-Amino-2-methyl-butyric acid hydrochloride | AA00FIOW | MFCD07368321
69688-50-2 | α-Chloro-α-methylbenzenepropionic acid methyl ester | AA00FLHY | MFCD22987373
66533-64-0 | 6-(Ethylthio)pyrazine-2-carboxylic acid | AA00FOC7 | MFCD00233249
740783-92-0 | 5-(Aminomethyl)isoxazole-3-carboxamide | AA00FTD0 | MFCD06804156
71725-02-5 | tert-Butyl 2,4-dibromobutyrate | AA00FV3G | MFCD00042954